Total Funding
48
69
Total FundingPre-Seed raised
Growth Score
-8 pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
116595
Orbits Oncology offers AI software for tumor data analysis, aiding cancer research and personalized medicine development.
- Abraham Lin: Co-Founder and CEO
- Maxim Compte: Co-Founder
About the Company
Orbits Oncology develops an AI-powered software platform that transforms patient tumor data into digital insights for cancer research. The platform focuses on organoid analysis, enabling researchers to gain insights into treatment-resistant and invasive subclones in cancers like pancreatic cancer. The software employs computer vision to track cells
without dyes, making it adaptable for various cancer models.
